• V. V. Klochko Igor Sikorsky Kyiv Polytechnic Institute; Zabolotny Institute of Microbiology and Virology of the National Academy of Sciences of Ukraine, Україна
  • U. O. Karpenko Igor Sikorsky Kyiv Polytechnic Institute, Україна

Ключові слова:

methicillin-resistant Staphylococcus aureus, MRSA, prevention, detection, treatment


This article is devoted to analysis of relevant information about methicillin-resistant Staphylococcus aureus, infections that it causes and available detection and treatment. The main danger that MRSA presents is due to its antibiotic resistance, high virulence and contact transmission route. Available treatment of MRSA associated infections consists of antibiotics, like vancomycin and daptomycin. New treatment and prevention methods are in development.


Methicillin-resistant Staphylococcus aureus / A. S. Lee et al. Nature reviews disease primers. 2018. Vol. 4, no. 1. URL:

Byrd A. L., Belkaid Y., Segre J. A. The human skin microbiome. Nature reviews microbiology. 2018. Vol. 16, no. 3. P. 143–155. URL:

Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research / N. A. Turner et al. Nature reviews microbiology. 2019. Vol. 17, no. 4. P. 203–218. URL:

A systematic review of transmission dynamic studies of methicillin-resistant Staphylococcus aureus in non-hospital residential facilities / K. O. Kwok et al. BMC infectious diseases. 2018. Vol. 18, no. 1. URL:

MRSA compendium of epidemiology, transmission, pathophysiology, treatment, and prevention within one health framework / M. Shoaib et al. Frontiers in microbiology. 2023. Vol. 13. URL:

Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype / K. M. Craft et al. MedChemComm. 2019. Vol. 10, no. 8. P. 1231–1241. URL:

Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities / J. E. Coia et al. Journal of hospital infection. 2021. Vol. 118. P. S1–S39. URL:

Comparison of screening for methicillin-resistant Staphylococcus aureus at hospital admission and discharge. Letters in biomathematics. 2021. Vol. 8, no. 1. URL:

Screening agars for MRSA: evaluation of a stepwise diagnostic approach with two different selective agars for the screening for methicillin-resistant Staphylococcus aureus (MRSA) / V. Micheel et al. Military medical research. 2015. Vol. 2, no. 1. URL:

Cong Y., Yang S., Rao X. Vancomycin resistant Staphylococcus aureus infections: a review of case updating and clinical features. Journal of advanced research. 2020. Vol. 21. P. 169–176. URL:

Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus: a comprehensive review / W.-T. Liu et al. Microbial pathogenesis. 2021. Vol. 156. P. 104915. URL:

Increasing multidrug antibiotic resistance in MRSA infections of the hand: a 10-year analysis of risk factors / J. M. Kistler et al. Hand. 2019. Vol. 15, no. 6. P. 877–881. URL:

Current paradigms of combination therapy in methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: does it work, which combination and for which patients? / W. Rose et al. Clinical infectious diseases. 2021. URL: (date of access: 25.04.2024).

Churkina L.N., Klochko V.V., Zagorodnya S.D., Yaroshenko L.V., Luitko O.B. Peculiarities of antibiotic batumin action on biofilm formation by Staphylococcus aureus and Pseudomonas batumici // Biotechnologia Acta, 2018. – v.11, № 2. – P. 72 –79.

Salvage bacteriophage therapy for a chronic MRSA prosthetic joint infection / J. B. Doub et al. Antibiotics. 2020. Vol. 9, no. 5. P. 241. URL: